Clinical Trial Update: Glycemic Variability, Gut Microbiota, and Prognosis in T2DM With ACS

View source ↗

Summary

A clinical trial is examining how glycemic variability and gut microbiota relate to prognosis in patients with type 2 diabetes mellitus and acute coronary syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Coronary Syndrome
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Second Affiliated Hospital of Nanchang University | Conditions: Type 2 Diabetes Mellitus, Coronary Heart Disease | Status: UNKNOWN